LEX Diagnostics
Melbourn, GB · 1 known investors
Lex Diagnostics develops in vitro diagnostic assays, including point-of-care molecular diagnostics, immunodiagnostics, and antimicrobial susceptibility testing. It works on assay development, reagent chemistry, and manufacturing transfer for regulated diagnostic products.
Founders & leadership
EF
Ed FarrellCEO
HD
Heather DanksCTO
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- LEX DIAGNOSTICS LIMITED
- Company number
- 12455716
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 11 Feb 2020
- Registered office
- Felindre Meadows, C/O Ortho Clinical Diagnostics, Felindre Meadows, Pencoed, CF35 5PZ
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 10 Feb 2026 · next due 24 Feb 2027
Current officers · 6
- Andrew Dwight Corkum — director, appointed 17 Apr 2026
- Edward Joseph Farrell — director, appointed 19 Jan 2023
- Salah Itani — director, appointed 17 Apr 2026
- Richard John Jenkins — director, appointed 17 Apr 2026
- Alastair James Manning — director, appointed 17 Apr 2026
- Edward Steven Moselle — director, appointed 17 Apr 2026
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does LEX Diagnostics do?
- Lex Diagnostics develops in vitro diagnostic assays, including point-of-care molecular diagnostics, immunodiagnostics, and antimicrobial susceptibility testing. It works on assay development, reagent chemistry, and manufacturing transfer for regulated diagnostic products.
- Who are LEX Diagnostics's investors?
- LEX Diagnostics's investors include TTP Ventures.
- Where is LEX Diagnostics headquartered?
- LEX Diagnostics is headquartered in Melbourn, GB.